Summit Therapeutics Inc. Common Stock SMMT

$17.40 +1.58% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-03 View →
8-K 8-K 2026-08-26 View →
8-K 8-K 2026-08-05 View →
8-K 8-K 2026-07-23 View →
424B5 424B5 2026-07-23 View →
10-Q 10-Q 2026-07-23 View →
8-K 8-K 2026-07-23 View →
8-K 8-K 2026-07-22 View →
8-K 8-K 2026-06-12 View →
4 FORM 4 2026-06-12 View →
4 FORM 4 2026-06-12 View →
8-K 8-K 2026-06-11 View →
424B5 424B5 2026-06-10 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
8-K 8-K 2026-06-03 View →
8-K 8-K 2026-06-01 View →
10-Q 10-Q 2026-04-30 View →
8-K 8-K 2026-04-30 View →
DEF 14A DEF 14A 2026-04-17 View →
10-K 10-K 2026-02-23 View →
8-K 8-K 2026-02-23 View →
8-K 8-K 2026-01-29 View →
4 FORM 4 2026-01-12 View →
8-K 8-K 2026-01-12 View →
4 FORM 4 2026-01-06 View →
4 FORM 4 2026-01-06 View →
4 FORM 4 2026-01-06 View →
4 FORM 4 2026-01-06 View →
4 FORM 4 2026-01-06 View →
4 FORM 4 2026-01-06 View →
4 FORM 4 2026-01-06 View →
4 FORM 4 2026-01-06 View →
8-K 8-K 2025-11-07 View →
4 FORM 4 2025-10-23 View →
4 FORM 4 2025-10-23 View →
4 FORM 4 2025-10-23 View →
4 FORM 4 2025-10-23 View →
4 FORM 4 2025-10-23 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$17.40
Market Cap
$13.67 billion
52-Week Range
$12.07 – $30.98
Average Volume
5.35 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.